Cytosorbents

 Cytosorb Guide

 Videos SETUP

Cases of week 2021

Cases of week 2022

Case of the mounth 2023   

thumbnail
0 comment

Use of CytoSorb in a patient with severe polytrauma and…

This case reports on a 20-year-old patient with no relevant medical history, who was admitted to the emergency room with severe polytrauma after hitting a stationary car whilst on his motorbike. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2023/01/CoW_01_2023_E_web_compressed_compressed.pdf"]

Read More
thumbnail
0 comment

The Sequential Use of Extracorporeal Cytokine Removal Devices in an…

This case reports on an a 14-year-boy (43 kg) without any respiratory symptoms, who was admitted to a regional hospital with a fever of one day associated with vomiting and breakthrough seizures. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2022/12/CoW_43_2022_E_web_compressed.pdf"]

Read More
thumbnail
0 comment

Use of hemadsorption in pediatric meningococcal sepsis, Waterhouse-Friderichsen-Syndrome, and multiple…

This case reports on an 18-year-old male without relevant medical history, who presented at the emergency room of a peripheral primary care hospital with nausea and headaches. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2022/12/CoW_42_2022_E_web_compressed.pdf"]

Read More
thumbnail
0 comment

Hemadsorption: A New Therapeutic Option for Selected Cases of Bromazepam…

This case reports on an a 67-year-old woman with CHILD-C liver cirrhosis, who was admitted to the tertiary intensive care unit (ICU) after intoxication with bromazepam. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2022/12/CoW_41_2022_E_web_compressed.pdf"]  

Read More
thumbnail
0 comment

Hemoadsorption as part of a multimodal therapy concept to treat…

This case reports on a 68-year-old male with known arterial hypertension, who presented at the hospital by ambulance following severe deterioration of his general condition including fever up to 39°C, oliguria and repeated vomiting over the recent days. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2022/11/CoW_40_2022_E_web_compressed.pdf"]  

Read More
thumbnail
0 comment

Use of CytoSorb for the treatment of Dengue shock syndrome…

This case reports on a 37-year-old male patient who was referred from a peripheral hospital with the diagnosis of Dengue fever and multiple organ failure. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2022/11/CoW_39_2022_E_web_compressed.pdf"]  

Read More
thumbnail
0 comment

CytoSorb hemoadsorption for removal of apixaban – a proof-of-concept pilot…

This case reports on an 81-year-old man who presented to the hospital with methicillin-sensitive Staphylococcus aureus prosthetic aortic valve endocarditis and hemodynamic instability requiring an urgent operation (EuroSCORE II 31.05%) [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2022/11/CoW_38_2022_E_web_compressed.pdf"]  

Read More
thumbnail
0 comment

Use of CytoSorb in a patient with ischemia-reperfusion injury, hemorrhagic…

This case reports on a 55-year-old man with hepatocellular carcinoma in the context of a hepatitis C virus (HCV)-infection since the year 2000, who was hospitalized and scheduled for an elective orthotopic liver transplantation. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2022/11/CoW_37_2022_E_web_compressed.pdf"]  

Read More
thumbnail
0 comment

Use of CytoSorb in drug-induced rhabdomyolysis

This report describes the case of a 73-year-old male patient (known pre-existing conditions: bilateral peripheral vascular disease grade 2b, hypercholesterolemia with long-term simvastatin medication) who was admitted to the Emergency Department with signs of marked weakness and hypersensitivity in his legs. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2022/11/CoW_022019_E_web_compressed.pdf"]  

Read More
thumbnail
0 comment

'Enhanced Lung Rest' with CytoSorb and ECMO Achieves High Survival…

Abstract PRINCETON, N.J., Nov. 2, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: ), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using its CytoSorb® blood purification technology, announced the presentation of the final key results from the U.S. multicenter  at the  in Paris last week.  CytoSorb was granted  in April 2020 for use in..

Read More